Products > IHC > Antibodies for immunohistochemistry

Antibodies for immunohistochemistry

Reach out to the antigen

In addition to the well-known own brand Zytomed Systems, the current program includes tried and tested reagents from Diagnostic Biosystems, BioCare Medical, Zeta Corporation among others. We are constantly testing new antibodies and detection systems to meet the specific requirements of the laboratories and scientific users in the best possible way. Most of the primary antibodies are available both as concentrates and as ready-to-use products.

Sorry, no results could be found for your request.
Products may not be approved or available in your region. Please check with your local Zytomed-Systems representative.
Product Clone Order no.
Host Rabbit
Clone polyclonal
Format Purified
Method F, P, IF, WB
Dilution 1:20 - 1:200
Isotype Rabbit IgG
Immunogen Whole cell preparation from B. burgdorferi
Borrelia burgdorferi 		polyclonal 602-0115
Host Rabbit
Clone polyclonal
Format Purified
Method IF, WB
Isotype Rabbit IgG
Immunogen Native, whole cells
Borrelia burgdorferi - FITC 		polyclonal 602-0118C
Host Mouse
Clone VE1
Format Concentrate
Reactivity CK, FG, MS
Method P, WB
Pretreatment Citrate
Positive control Colon Carcinoma with BRAF V600E mutation
Dilution 1:100
Immunogen Synthetic peptide representing the BRAF V600E mutated amino acid sequence from amino acid 596 to 606 (GLATEKSRWSG).
BRAF V600E 		VE1 AB228461-0.1 ML
Host Mouse
Clone VE1
Format Concentrate
Reactivity CK, FG, MS
Method P, WB
Pretreatment Citrate
Positive control Colon Carcinoma with BRAF V600E mutation
Dilution 1:100
Immunogen Synthetic peptide representing the BRAF V600E mutated amino acid sequence from amino acid 596 to 606 (GLATEKSRWSG).
BRAF V600E 		VE1 AB228461-0.5 ML
Host Mouse
Clone VE1
Format Concentrate
Reactivity CK, FG, MS
Method P, WB
Pretreatment Citrate
Positive control Colon Carcinoma with BRAF V600E mutation
Dilution 1:100
Immunogen Synthetic peptide representing the BRAF V600E mutated amino acid sequence from amino acid 596 to 606 (GLATEKSRWSG).
BRAF V600E 		VE1 AB228461-1.0 ML
Host Mouse
Clone MS110
Format Purified
Method F, P, FL, WB, IF, IP
Pretreatment Citrate
Positive control Breast carcinoma
Isotype Mouse IgG1
Immunogen Recombinant protein corresponding to the N-Terminal region of human BRCA1
BRCA1 		MS110 602-0170
Host Mouse
Clone GLK-2
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Ovary Carcinoma
Dilution 1:15 - 1:50
Isotype Mouse IgM
Localization Cytoplasm
BRCA1 		GLK-2 MOB424
Host Mouse
Clone GLK-2
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Ovary Carcinoma
Dilution 1:15 - 1:50
Isotype Mouse IgM
Localization Cytoplasm
BRCA1 		GLK-2 MOB424-01
Host Mouse
Clone GLK-2
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Ovary Carcinoma
Dilution 1:15 - 1:50
Isotype Mouse IgM
Localization Cytoplasm
BRCA1 		GLK-2 MOB424-05
Host Mouse
Clone MS110
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Breast carcinoma with BRCA-1 gene mutation.
Dilution 1:50 - 1:100
Isotype IgG1 /κ
Immunogen BRCA-1
Localization Nucleus
BRCA1 		MS110 Z2237ML
Host Mouse
Clone MS110
Format Ready-to-use
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Breast carcinoma with BRCA-1 gene mutation.
Dilution -
Isotype IgG1 /κ
Immunogen BRCA-1
Localization Nucleus
BRCA1 		MS110 Z2237MP
Host Mouse
Clone MS110
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Breast carcinoma with BRCA-1 gene mutation.
Dilution 1:50 - 1:100
Isotype IgG1 /κ
Immunogen BRCA-1
Localization Nucleus
BRCA1 		MS110 Z2237MS
Host Mouse
Clone MS110
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Breast carcinoma with BRCA-1 gene mutation.
Dilution 1:50 - 1:100
Isotype IgG1 /κ
Immunogen BRCA-1
Localization Nucleus
BRCA1 		MS110 Z2237MT
Host Mouse
Clone Bu20a
Format Purified
Method F, P, FL
Isotype Mouse IgG1
Immunogen Bromodeoxyuridine conjugated to BSA
Bromodeoxyuridine (BrdU) 		Bu20a 602-0135
Host Mouse
Clone Bu20a
Format Purified
Method F, P, FL
Isotype Mouse IgG1
Immunogen Bromodeoxyuridine conjugated to BSA
Bromodeoxyuridine (BrdU) 		Bu20a 602-0180
Host Rabbit
Clone polyclonal
Format Concentrate
Method P,F
Dilution 1:20 - 1:40
Isotype Rabbit Ig
C1q-FITC 		polyclonal F010
Host Rabbit
Clone polyclonal
Format Concentrate
Method P,F
Dilution 1:20 - 1:40
Isotype Rabbit Ig
C1q-FITC 		polyclonal F010-01
Host Rabbit
Clone polyclonal
Format Concentrate
Method P,F
Dilution 1:75 - 1:100
Isotype Rabbit Ig
C3c-FITC 		polyclonal F003
Host Rabbit
Clone polyclonal
Format Concentrate
Method P,F
Dilution 1:75 - 1:100
Isotype Rabbit Ig
C3c-FITC 		polyclonal F003-01
Host Mouse
Clone ZM369
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Acute rejected kidney transplant
Dilution 1:100 - 1:200
Isotype IgG2b/κ
Immunogen Recombinant full-length human Complement C3 protein
Localization Membrane or Cytoplasm
C3d 		ZM369 Z2660ML
Host Mouse
Clone ZM369
Format ready-to-use
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Acute rejected kidney transplant
Dilution ---
Isotype IgG2b/κ
Immunogen Recombinant full-length human Complement C3 protein
Localization Membrane or Cytoplasm
C3d 		ZM369 Z2660MP
Host Mouse
Clone ZM369
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Acute rejected kidney transplant
Dilution 1:100 - 1:200
Isotype IgG2b/κ
Immunogen Recombinant full-length human Complement C3 protein
Localization Membrane or Cytoplasm
C3d 		ZM369 Z2660MS
Host Mouse
Clone ZM369
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Acute rejected kidney transplant
Dilution 1:100 - 1:200
Isotype IgG2b/κ
Immunogen Recombinant full-length human Complement C3 protein
Localization Membrane or Cytoplasm
C3d 		ZM369 Z2660MT
Host Rabbit
Clone polyclonal
Format Concentrate
Method P,F
Dilution 1:50 - 1:100
Isotype Rabbit Ig
C4c-FITC 		polyclonal F005
Host Rabbit
Clone polyclonal
Format Concentrate
Method P,F
Dilution 1:50 - 1:100
Isotype Rabbit Ig
C4c-FITC 		polyclonal F005-01
Host Rabbit
Clone polyclonal
Format Concentrate
Method F, P
Pretreatment Citrate
Dilution 1:50
Isotype Rabbit Ig
Immunogen Synthetic peptide specific for human complement C4d conjugated to KLH (keyhole limpet hemocyanin)
C4d 		polyclonal A12-5000
Host Mouse
Clone ZM78
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Acute rejected kidney transplant.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Recombinant full-length human complement 4d protein
Localization Membrane or Cytoplasm
C4d (Complement factor) 		ZM78 Z2388ML
Host Mouse
Clone ZM78
Format Ready-to-use
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Acute rejected kidney transplant.
Dilution -
Isotype IgG1 /κ
Immunogen Recombinant full-length human complement 4d protein
Localization Membrane or Cytoplasm
C4d (Complement factor) 		ZM78 Z2388MP
Host Mouse
Clone ZM78
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Acute rejected kidney transplant.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Recombinant full-length human complement 4d protein
Localization Membrane or Cytoplasm
C4d (Complement factor) 		ZM78 Z2388MS
Host Mouse
Clone ZM78
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Acute rejected kidney transplant.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Recombinant full-length human complement 4d protein
Localization Membrane or Cytoplasm
C4d (Complement factor) 		ZM78 Z2388MT
Host Mouse
Clone C4D204
Format Concentrate
Method P
Pretreatment EDTA
Positive control rejected kidney
Dilution 1:50 - 1:100
Isotype Mouse IgG1
Immunogen A recombinant fragment specific to Complement 4d
Localization Cell membrane, Cytoplasm
C4d Komplementfaktor 		C4D204 MOB471
Host Mouse
Clone C4D204
Format Concentrate
Method P
Pretreatment EDTA
Positive control rejected kidney
Dilution 1:50 - 1:100
Isotype Mouse IgG1
Immunogen A recombinant fragment specific to Complement 4d
Localization Cell membrane, Cytoplasm
C4d Komplementfaktor 		C4D204 MOB471-01
Host Mouse
Clone C4D204
Format Concentrate
Method P
Pretreatment EDTA
Positive control rejected kidney
Dilution 1:50 - 1:100
Isotype Mouse IgG1
Immunogen A recombinant fragment specific to Complement 4d
Localization Cell membrane, Cytoplasm
C4d Komplementfaktor 		C4D204 MOB471-05
Host Mouse
Clone DBMM1
Format Concentrate
Method P
Pretreatment EDTA
Positive control Breast carcinoma
Dilution 1:50 - 1:100
Isotype IgG1 kappa
Localization Cytoplasm, cell membrane
CA 15-3 		DBMM1 MOB549
Host Mouse
Clone DBMM1
Format Concentrate
Method P
Pretreatment EDTA
Positive control Breast carcinoma
Dilution 1:50 - 1:100
Isotype IgG1 kappa
Localization Cytoplasm, cell membrane
CA 15-3 		DBMM1 MOB549-01
Host Mouse
Clone DBMM1
Format Concentrate
Method P
Pretreatment EDTA
Positive control Breast carcinoma
Dilution 1:50 - 1:100
Isotype IgG1 kappa
Localization Cytoplasm, cell membrane
CA 15-3 		DBMM1 MOB549-05
Host Mouse
Clone DBMM1
Format Ready-to-use
Method P
Pretreatment EDTA
Positive control Breast carcinoma
Dilution -
Isotype IgG1 kappa
Localization Cytoplasm, cell membrane
CA 15-3 		DBMM1 PDM549
Host Mouse
Clone C241:5:1:4
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Colon Carcinoma
Dilution 1:25 - 1:50
Isotype Mouse IgG1
Localization Cytoplasm
CA 19-9 Antigen (Colon) 		C241:5:1:4 MOB109
Host Mouse
Clone C241:5:1:4
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Colon Carcinoma
Dilution 1:25 - 1:50
Isotype Mouse IgG1
Localization Cytoplasm
CA 19-9 Antigen (Colon) 		C241:5:1:4 MOB109-01
Host Mouse
Clone C241:5:1:4
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Colon Carcinoma
Dilution 1:25 - 1:50
Isotype Mouse IgG1
Localization Cytoplasm
CA 19-9 Antigen (Colon) 		C241:5:1:4 MOB109-05
Host Mouse
Clone B72.3
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Breast Carcinoma
Dilution 1:50 - 1:100
Isotype Mouse IgG1
Localization Cytoplasmic, Cell Surface
CA 72.4 Antigen (TAG-72, BRST3) 		B72.3 MOB288
Host Mouse
Clone B72.3
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Breast Carcinoma
Dilution 1:50 - 1:100
Isotype Mouse IgG1
Localization Cytoplasmic, Cell Surface
CA 72.4 Antigen (TAG-72, BRST3) 		B72.3 MOB288-01
Host Mouse
Clone B72.3
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Breast Carcinoma
Dilution 1:50 - 1:100
Isotype Mouse IgG1
Localization Cytoplasmic, Cell Surface
CA 72.4 Antigen (TAG-72, BRST3) 		B72.3 MOB288-05
Host Mouse
Clone B72.3
Format Ready-to-use
Method F, P
Pretreatment Citrate
Positive control Breast Carcinoma
Dilution -
Isotype Mouse IgG1
Localization Cytoplasmic, Cell Surface
CA 72.4 Antigen (TAG-72, BRST3) 		B72.3 PDM100
Host Mouse
Clone Ov185:1
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Ovary Carcinoma, AdenoCarcinoma
Dilution 1:25 - 1:50
Isotype Mouse IgG1
Localization Extracellular Membrane
CA 125 Antigen (Ovary) 		Ov185:1 MOB110
Host Mouse
Clone Ov185:1
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Ovary Carcinoma, AdenoCarcinoma
Dilution 1:25 - 1:50
Isotype Mouse IgG1
Localization Extracellular Membrane
CA 125 Antigen (Ovary) 		Ov185:1 MOB110-01
Host Mouse
Clone Ov185:1
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Ovary Carcinoma, AdenoCarcinoma
Dilution 1:25 - 1:50
Isotype Mouse IgG1
Localization Extracellular Membrane
CA 125 Antigen (Ovary) 		Ov185:1 MOB110-05
Host Mouse
Clone ZM53
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Ovarian carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Full length native CA125 protein purified from human ovarian carcinoma
Localization Extracellular membrane-associated.
CA 125/ MUC16 		ZM53 Z2363ML
Host Mouse
Clone ZM53
Format Ready-to-use
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Ovarian carcinoma.
Dilution -
Isotype IgG1 /κ
Immunogen Full length native CA125 protein purified from human ovarian carcinoma
Localization Extracellular membrane-associated.
CA 125/ MUC16 		ZM53 Z2363MP
Host Mouse
Clone ZM53
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Ovarian carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Full length native CA125 protein purified from human ovarian carcinoma
Localization Extracellular membrane-associated.
CA 125/ MUC16 		ZM53 Z2363MS
< Page 5 of 65 >
Products may not be approved or available in your region. Please check with your local Zytomed-Systems representative.
Product Clone Order no.
Load more

Key to the method:

EL = ELISA; F = Frozen section IHC; FL = Flow Cytometry; IF = Immunfluoreszenz; IP = Immunoprecipitation; P = Paraffin section IHC; WB = Western Blot; u. a. = and others

Products

Topics

Learning videos

Downloads

Company

Distributors

Privacy Imprint
DE EN

Product availability

Products may not be approved or available in your region. Please check with your local Zytomed-Systems representative.

Got it